AnalystsMark BreidenbachMark Breidenbach's Stock Forecasts
AnalystsMark Breidenbach
Sectors:
Industries:
Analyst Ranking
Top 9%
#396 out of 4559 analysts
Average Return
+22.5%
Win Rate
40%25 out of 62
Risk vs Reward
Poor
Good
Mark Breidenbach's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +490.31% | $10.94 | $64.58 | 2023-06-25 - 2024-04-22 | Buy |
Seres Therapeutics IncMCRB | +476.75% | $3.57 | $20.59 | 2020-03-30 - 2021-03-31 | Buy |
Alpine Immune Sciences IncALPN | +428.05% | $7.45 | $39.34 | 2023-03-23 - 2024-03-22 | Buy |
Alpine Immune Sciences IncALPN | +402.57% | $12.85 | $64.58 | 2023-09-10 - 2024-04-22 | Buy |
Compugen LtdCGEN | +225.32% | $0.79 | $2.57 | 2023-02-27 - 2024-02-28 | Buy |
Mark Breidenbach Analyst Color
Get additional color on Mark Breidenbach's coverage of popular stocks
Mark Breidenbach's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Essa Pharma IncEPIX | 4 | Buy | $17.00 | +165.63% | Reiterates | 4 months ago |
Alpine Immune Sciences IncALPN | 4 | Buy | $22.00 | -65.93% | Maintains | 7 months ago |
Arvinas IncARVN | 5 | Buy | $95.00 | +172.21% | Reiterates | 8 months ago |
Immuneering CorpIMRX | 3 | Buy | $25.00 | +1,353.49% | Reiterates | 8 months ago |
Allogene Therapeutics IncALLO | 4 | Buy | $28.00 | +723.53% | Reiterates | 9 months ago |
Cue Biopharma IncCUE | 5 | Buy | $10.00 | +536.94% | Assumes | 10 months ago |
Seres Therapeutics IncMCRB | 4 | Buy | $12.00 | +1,820.00% | Assumes | 10 months ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $25.00 | +84.09% | Assumes | 10 months ago |
Biolinerx LtdBLRX | 1 | Buy | $4.00 | +490.84% | Reiterates | a year ago |
Gamida Cell LtdGMDAQ | 4 | Buy | $6.00 | +18,081.82% | Maintains | a year ago |
Compugen LtdCGEN | 6 | Buy | $7.00 | +270.37% | Maintains | a year ago |
Caribou Biosciences IncCRBU | 2 | Buy | $32.00 | N/A | Maintains | a year ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $13.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $15.00 | N/A | Maintains | a year ago |
Synlogic IncSYBX | 2 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $86.00 | N/A | Maintains | 2 years ago |
Kadmon Holdings IncKDMN | 1 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Achilles Therapeutics PLCACHL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Mustang Bio IncMBIO | 2 | Buy | $195.00 | N/A | Maintains | 4 years ago |
Bluebird Bio IncBLUE | 2 | Buy | $135.00 | N/A | Upgrades | 4 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Buy | $6.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.